Symptoms include confusion, dizziness, and excessive sweating
Findings align with previous studies where low volume doses of dulaglutide and semaglutide, 0.75 and 0.25 mg respectively, are prescribed at first dispensation, and are reviewed and often increased at follow-up [13]
Even though it is a drug with few systemic adverse effects, the gastrointestinal symptoms that are triggered have been considered a recurrent problem with this group of medications.6,7 Dipeptidyl peptidase 4 inhibitors Incretins are intestinal peptides that are secreted after eating foods that, together with hyperglycemia, stimulate insulin release and play an essential role in glucose homeostasis
GLP-1s are still relevant to the growth narrative: management disclosed $230M (39%) in Q1 2025 and $190M (35%) in Q2 2025
There are many app plus pill combinations or companion solutions available on the digital health market
With semaglutide, many individuals report a significant decrease in cravings for unhealthy foods